Uniphar

Uniphar is a company listed under the stock ticker UPR (GB).

Uniphar has a direct presence in 2 countries.

View the org chart displaying its 20 main executives

Most searched biographies at Uniphar

• Ger Rabbette, Chief Executive Officer and Director
• Jeff Berkowitz, Independent Non-Executive Director
• Maurice Pratt, Chairman of the Board

Create an alert
to follow the executive moves at Uniphar.

Uniphar has 1,999 competitors including Pfizer (United States (USA)), Johnson & Johnson (United States (USA)) and Roche (Switzerland).

Popular M&A news in Pharmaceuticals

• Zentalis Pharmaceuticals has just announced a $200 Million fundraising. (posted on May 19 2022).
• Pfizer has announced the acquisition of Biohaven Pharmaceutical  (posted on May 12 2022).
• Corden Pharma and Astorg Partners have announced they will merge  (posted on May 4 2022)..

Popular contacts in Pharmaceuticals

• Albert Bourla - Chief Executive Officer and Chairman of the Board at Pfizer
• Joaquin Duato - Chief Executive Officer and Director at Johnson & Johnson
• Luisa Bartorelli - Chief Patent Counsel at Cosmo Pharmaceuticals

Learn more about the Pharmaceuticals industry >

Press releases by Uniphar

• Uniphar to buy CoRRect Medical as it accelerates entrance to German market
• Uniphar sees profit and earnings growth despite Covid challenge
• Uniphar to buy Hickey's pharma chain as half yearly profits rise
• Uniphar acquires US pharmaceutical advisory group
• CROSS Charity Cycle 2017 Press Release

Social media about Uniphar

• Uniphar on Wikipedia, Google News & Yahoo Finance
• Uniphar on LinkedIn, Twitter & YouTube

Contact by email its executives including Ger Rabbette

Call Uniphar at +353 ...

View the org chart

Register to receive your alert

Report an error